AN IONIC-GELLING ALGINATE DRINK ATTENUATES 1 determine the glycaemic response to a controlled test-23 lunch of mixed composition following an ionic-gelling 24 alginate preload drink compared to an acidic-gelling 25
control. 26
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Study Design 180
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Preload Formulations and Glycaemia 203
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